Terms: = Leukemia AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Prognosis
48 results:
1. A novel TCGA-validated programmed cell-death-related signature of ovarian cancer.
Cai X; Lin J; Liu L; Zheng J; Liu Q; Ji L; Sun Y
BMC Cancer; 2024 Apr; 24(1):515. PubMed ID: 38654239
[TBL] [Abstract] [Full Text] [Related]
2. BCL-X
Jenkins LJ; Luk IY; Chionh F; Tan T; Needham K; Ayton J; Reehorst CM; Vukelic N; Sieber OM; Mouradov D; Gibbs P; Williams DS; Tebbutt NC; Desai J; Hollande F; Dhillon AS; Lee EF; Merino D; Fairlie WD; Mariadason JM
Cell Death Dis; 2024 Mar; 15(3):183. PubMed ID: 38429301
[TBL] [Abstract] [Full Text] [Related]
3. Mutant NPM1 maintains RASGRP3 protein stability via interaction with MID1 to promote acute myeloid leukemia cell proliferation and autophagy.
Wang Y; Pan C; Zhang X; Zhao A; Dong Y
J Leukoc Biol; 2023 May; 113(5):504-517. PubMed ID: 36826998
[TBL] [Abstract] [Full Text] [Related]
4. Interferon gamma regulates a complex pro-survival signal network in chronic lymphocytic leukemia.
Chen Y; Shao X; Yang H; Ren L; Cui Y; Zhang W; Macip S; Meng X
Eur J Haematol; 2023 Apr; 110(4):435-443. PubMed ID: 36576398
[TBL] [Abstract] [Full Text] [Related]
5. Identification of a signature based on non-apoptotic regulatory cell death to improve prognosis prediction in acute myeloid leukaemia.
Zheng Y; Weng X; Hu D; He J
Br J Haematol; 2023 Apr; 201(1):95-105. PubMed ID: 36484284
[TBL] [Abstract] [Full Text] [Related]
6. Electrostatic anti-CD33-antibody-protamine nanocarriers as platform for a targeted treatment of acute myeloid leukemia.
Bäumer N; Scheller A; Wittmann L; Faust A; Apel M; Nimmagadda SC; Geyer C; Grunert K; Kellmann N; Peipp M; Kailayangiri S; Gutierrez Suburu ME; Strassert CA; Schenk M; Greune L; Rüter C; Dersch P; Hartmann W; Rossig C; Neri D; Müller-Tidow C; Schwöppe C; Schliemann C; Khandanpour C; Lenz G; Berdel WE; Bäumer S
J Hematol Oncol; 2022 Dec; 15(1):171. PubMed ID: 36457063
[TBL] [Abstract] [Full Text] [Related]
7. Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract.
Wu H; Yu Z; Liu Y; Guo L; Teng L; Guo L; Liang L; Wang J; Gao J; Li R; Yang L; Nie X; Su D; Liang Z
Cancer Commun (Lond); 2022 Dec; 42(12):1367-1386. PubMed ID: 36264285
[TBL] [Abstract] [Full Text] [Related]
8. Upregulated SPAG6 promotes acute myeloid leukemia progression through MYO1D that regulates the egfr family expression.
Mu J; Yuan P; Luo J; Chen Y; Tian Y; Ding L; Zhao B; Wang X; Wang B; Liu L
Blood Adv; 2022 Sep; 6(18):5379-5394. PubMed ID: 35667090
[TBL] [Abstract] [Full Text] [Related]
9. Comprehensive omics analyses profile genesets related with tumor heterogeneity of multifocal glioblastomas and reveal LIF/CCL2 as biomarkers for mesenchymal subtype.
Lv SQ; Fu Z; Yang L; Li QR; Zhu J; Gai QJ; Mao M; He J; Qin Y; Yao XX; Lan X; Wang YX; Lu HM; Xiang Y; Zhang ZX; Huang GH; Yang W; Kang P; Sun Z; Shi Y; Yao XH; Bian XW; Wang Y
Theranostics; 2022; 12(1):459-473. PubMed ID: 34987659
[No Abstract] [Full Text] [Related]
10. [Clinical analysis of 12 cases of acute myeloid leukemia complicated with synchronous primary solid tumor].
Mi RH; Dang HB; Chen L; Han YL; Wang MF; Zhang YL; Chen L; Li DB; Wei XD
Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(42):3323-3327. PubMed ID: 33202495
[No Abstract] [Full Text] [Related]
11. Clinicopathological Significance of Common Genetic Alterations in Patients With Acute Promyelocytic leukemia.
Nath S; Bhattacharyya J; Chandra P; Saxena R; Sazawal S; Saikia KK
Hematol Oncol Stem Cell Ther; 2022 Jun; 15(2):54-57. PubMed ID: 32755558
[TBL] [Abstract] [Full Text] [Related]
12. Integrative Network Analysis of Differentially Methylated and Expressed Genes for Biomarker Identification in leukemia.
Sanchez R; Mackenzie SA
Sci Rep; 2020 Feb; 10(1):2123. PubMed ID: 32034170
[TBL] [Abstract] [Full Text] [Related]
13. Combined SRPK and AKT pharmacological inhibition is synergistic in T-cell acute lymphoblastic leukemia cells.
Siqueira RP; Caetano MMM; de Souza LÂ; Dos Passos PMS; Simaroli NB; Barros MVA; de Souza APM; de Oliveira LL; Silva-Júnior A; Fietto JLR; Teixeira RR; Teixeira FR; Bressan GC
Toxicol In Vitro; 2020 Jun; 65():104777. PubMed ID: 31962201
[TBL] [Abstract] [Full Text] [Related]
14. Ecotropic viral integration site 1 regulates egfr transcription in glioblastoma cells.
Mizuguchi A; Yamashita S; Yokogami K; Morishita K; Takeshima H
J Neurooncol; 2019 Nov; 145(2):223-231. PubMed ID: 31617054
[TBL] [Abstract] [Full Text] [Related]
15. Molecular profiling of adult acute myeloid and lymphoid leukemia in a major referral center in Lebanon: a 10-year experience report and review of the literature.
Assaf N; El-Cheikh J; Bazarbachi A; Salem Z; Farra C; Chakhachiro Z; Nassif S; Zaatari G; Mahfouz R
Mol Biol Rep; 2019 Apr; 46(2):2003-2011. PubMed ID: 30701458
[TBL] [Abstract] [Full Text] [Related]
16. TCF7L2 activated HOXA-AS2 decreased the glucocorticoid sensitivity in acute lymphoblastic leukemia through regulating HOXA3/egfr/Ras/Raf/MEK/ERK pathway.
Zhao Q; Zhao S; Li J; Zhang H; Qian C; Wang H; Liu J; Zhao Y
Biomed Pharmacother; 2019 Jan; 109():1640-1649. PubMed ID: 30551418
[TBL] [Abstract] [Full Text] [Related]
17. Dancing from bottoms up - Roles of the POZ-ZF transcription factor Kaiso in Cancer.
Pierre CC; Hercules SM; Yates C; Daniel JM
Biochim Biophys Acta Rev Cancer; 2019 Jan; 1871(1):64-74. PubMed ID: 30419310
[TBL] [Abstract] [Full Text] [Related]
18. Screening of prognostic risk microRNAs for acute myeloid leukemia.
Gao HY; Wang W; Luo XG; Jiang YF; He X; Xu P; Chen X; Li XY
Hematology; 2018 Dec; 23(10):747-755. PubMed ID: 29781401
[TBL] [Abstract] [Full Text] [Related]
19. ZAP-70 in chronic lymphocytic leukemia: A meta-analysis.
Liu Y; Wang Y; Yang J; Bi Y; Wang H
Clin Chim Acta; 2018 Aug; 483():82-88. PubMed ID: 29680229
[TBL] [Abstract] [Full Text] [Related]
20. Molecular mechanisms of breast cancer metastasis by gene expression profile analysis.
Zheng T; Wang A; Hu D; Wang Y
Mol Med Rep; 2017 Oct; 16(4):4671-4677. PubMed ID: 28791367
[TBL] [Abstract] [Full Text] [Related]
[Next]